In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now ...

The Neon is dependable, economical and you can pretty much drive it on any type of road. I'm still looking for "the" one. Great car, nice styling and fun.

Actual terms vary by lender. Here we are in 2022, and I still drive a 2004 Dodge Neon. This thing just will not quit (yet). People ask why I don't get a new car...why would I want the monthly ...

SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biotechnology company currently valued at $968 million, recently sold a total of 4,000 shares of the company's ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13 ... for patients with cancer in need of new treatment options, and Decoy Therapeutics, Inc., a privately held preclinical biopharmaceutical company ...

A microscope image of lung cancer cells (purple) containing the activated form of a metabolic enzyme called GUK1 (brown) that supports cancer growth. Researchers discovered the importance of an ...

However, Wall Street's enthusiasm for Summit Therapeutics appears to be justified. If ivonescimab fulfills its potential, Summit should be worth a lot more within a few years than it is today.

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...

Gainers: SYBX +26%. NTEC +15%. VERU +14%. CRSP +13%. BCRX +13%.Losers: MRUS -16%. VTVT -11%. TSRO -9%. OREX -9%. RIOT -7%.Now read: Tesaro (TSRO) Presents At Citi ...

In recent years, mindfulness and acceptance-based therapies have emerged as crucial tools in our therapeutic toolkit, especially for addressing anxiety, depression, and trauma. Techniques like ...